Abstract
Purpose
Pharmacological treatment is a cornerstone in asthma management, but there is limited evidence on how adolescents use their medication and to what extent their asthma is under control. Therefore, the aim of this study was to compare self-reported and register-based medicine use in asthmatic adolescents. Furthermore, we investigated the association between medicine use, patient characteristics, and degree of asthma control.
Methods
Cross-sectional analyses of 331 adolescents with asthma from a population-based birth cohort linked to data from the Swedish Prescribed Drug Register. Adolescents’ asthma medicine use was assessed with three approaches: self-reported medicine use, self-reported use of someone else’s medicines, and dispensed medicines from pharmacies during an 18-month period. Medicine use in adolescents with and without asthma control were compared.
Results
In total, 82 % reported use of asthma medicines, 10 % reported use of someone else’s medicines, and 62 % were dispensed asthma medicines from pharmacies. Among adolescents with self-reported medicine use, 22 % (n = 60) were neither dispensed medicines nor using someone else’s medicines. The majority of those using someone else’s medicines had also been dispensed asthma medicine (22 out of 33). Among adolescents with asthma, 176 were fully controlled and 155 were uncontrolled. Also, boys had higher odds of having asthma control than girls.
Conclusion
Most adolescents with asthma reported use of asthma medicines, but a considerable proportion were neither dispensed any medicines nor using someone else’s medicines. Girls were less likely to achieve asthma control. It is important to combine data sources to understand medicine use among adolescents with asthma.
Similar content being viewed by others
References
Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, Group IPTS (2007) Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62(9):758–766. doi:10.1136/thx.2006.070169
de Benedictis D, Bush A (2007) The challenge of asthma in adolescence. Pediatr Pulmonol 42(8):683–692. doi:10.1002/ppul.20650
Couriel J (2003) Asthma in adolescence. Paediatr Respir Rev 4(1):47–54
Globale Initiative for Asthma G (2014) Global strategy for asthma management and prevention
Alvim CG, Picinin IM, Camargos PM, Colosimo E, Lasmar LB, Ibiapina CC, Fontes MJ, Andrade CR (2009) Quality of life in asthmatic adolescents: an overall evaluation of disease control. J Asthma 46(2):186–190. doi:10.1080/02770900802604129
Coons SJ, Rao S, Keininger DL, Hays RD (2000) A comparative review of generic quality-of-life instruments. PharmacoEconomics 17(1):13–35
Ravens-Sieberer U, Erhart M, Wille N, Wetzel R, Nickel J, Bullinger M (2006) Generic health-related quality-of-life assessment in children and adolescents: methodological considerations. PharmacoEconomics 24(12):1199–1220
Lundberg O, Manderbacka K (1996) Assessing reliability of a measure of self-rated health. Scand J Soc Med 24(3):218–224
Wisnivesky JP, Lorenzo J, Lyn-Cook R, Newman T, Aponte A, Kiefer E, Halm EA (2008) Barriers to adherence to asthma management guidelines among inner-city primary care providers. Ann Allergy Asthma Immunol 101(3):264–270. doi:10.1016/S1081-1206(10)60491-7
Desai M, Oppenheimer JJ (2011) Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep 11(6):454–464. doi:10.1007/s11882-011-0227-2
Ingemansson M, Wettermark B, Jonsson EW, Bredgard M, Jonsson M, Hedlin G, Kiessling A (2012) Adherence to guidelines for drug treatment of asthma in children: potential for improvement in Swedish primary care. Qual Prim Care 20(2):131–139
Breekveldt-Postma NS, Koerselman J, Erkens JA, van der Molen T, Lammers JW, Herings RM, Appendix CSGlit (2008) Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf 17(4):411–422. doi:10.1002/pds.1552
Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH (2000) Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 117(2):542–550
Dahlen E, Almqvist C, Bergstrom A, Wettermark B, Kull I (2014) Factors associated with concordance between parental-reported use and dispensed asthma drugs in adolescents: findings from the BAMSE birth cohort. Pharmacoepidemiol Drug Saf 23(9):942–949. doi:10.1002/pds.3662
Furu K, Karlstad O, Skurtveit S, Haberg SE, Nafstad P, London SJ, Nystad W (2011) High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database. J Clin Epidemiol 64(8):878–884. doi:10.1016/j.jclinepi.2010.10.014
Nwaru BI, Lumia M, Kaila M, Luukkainen P, Tapanainen H, Erkkola M, Ahonen S, Pekkanen J, Klaukka T, Veijola R, Simell O, Knip M, Virtanen SM (2011) Validation of the Finnish ISAAC questionnaire on asthma against anti-asthmatic medication reimbursement database in 5-year-old children. Clin Respir J 5(4):211–218. doi:10.1111/j.1752-699X.2010.00222.x
Wogelius P, Poulsen S, Sorensen HT (2005) Validity of parental-reported questionnaire data on Danish children’s use of asthma-drugs: a comparison with a population-based prescription database. Eur J Epidemiol 20(1):17–22
Koster ES, Wijga AH, Raaijmakers JA, Koppelman GH, Postma DS, Kerkhof M, Hoekstra MO, de Jongste JC, Smit HA, Brunekreef B, Maitland-van der Zee AH (2010) High agreement between parental reported inhaled corticosteroid use and pharmacy prescription data. Pharmacoepidemiol Drug Saf 19(11):1199–1203. doi:10.1002/pds.2015
Wickman M, Kull I, Pershagen G, Nordvall SL (2002) The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol 13(Suppl 15):11–13
Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11):659–667. doi:10.1007/s10654-009-9350-y
Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735. doi:10.1002/pds.1294
Pharmaceutical Benefits Act (2002:160 5§).
Pinart M, Benet M, Annesi-Maesano I, von Berg A, Berdel D, Carlsen KC, Carlsen KH, Bindslev-Jensen C, Eller E, Fantini MP, Lenzi J, Gehring U, Heinrich J, Hohmann C, Just J, Keil T, Kerkhof M, Kogevinas M, Koletzko S, Koppelman GH, Kull I, Lau S, Melen E, Momas I, Porta D, Postma DS, Ranciere F, Smit HA, Stein RT, Tischer CG, Torrent M, Wickman M, Wijga AH, Bousquet J, Sunyer J, Basagana X, Guerra S, Garcia-Aymerich J, Anto JM (2014) Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2(2):131–140. doi:10.1016/S2213-2600(13)70277-7
WHO Collaborating Center for Drug Statistics Methodology. Oslo guidelines for ATC classification and DDD assignment, 2015
Almqvist C, Worm M, Leynaert B, Working Group of GALENWPG (2008) Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63(1):47–57. doi:10.1111/j.1398-9995.2007.01524.x
Nordlund B, Melen E, Schultz ES, Gronlund H, Hedlin G, Kull I (2014) Risk factors and markers of asthma control differ between asthma subtypes in children. Pediatr Allergy Immunol 25(6):558–564. doi:10.1111/pai.12271
Goldsworthy RC, Mayhorn CB (2009) Prescription medication sharing among adolescents: prevalence, risks, and outcomes. J Adolesc Health 45(6):634–637. doi:10.1016/j.jadohealth.2009.06.002
Goulding E, Murphy M, Di Blasi Z (2011) Sharing and borrowing prescription medication: a survey of Irish college students. Ir J Med Sci 180(3):687–690. doi:10.1007/s11845-011-0698-0
Ortqvist AK, Lundholm C, Wettermark B, Ludvigsson JF, Ye W, Almqvist C (2013) Validation of asthma and eczema in population-based Swedish drug and patient registers. Pharmacoepidemiol Drug Saf 22(8):850–860. doi:10.1002/pds.3465
Davidsen JR, Hallas J, Sondergaard J, Christensen RD, Siersted HC, Hansen MP, Knudsen TB, Lykkegaard J, Andersen M (2011) Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: a cross-sectional study. Pulm Pharmacol Ther 24(6):647–653. doi:10.1016/j.pupt.2011.09.001
Klok T, Kaptein AA, Duiverman EJ, Brand PL (2014) It’s the adherence, stupid (that determines asthma control in preschool children)! Eur Respir J 43(3):783–791. doi:10.1183/09031936.00054613
Swedish Code of Statutes, Act 2002:687.
Acknowledgments
The authors would like to thank all participants and staff in the BAMSE study. We acknowledge financial support from the Swedish Research Council, the Swedish Asthma and Allergy Foundation, the European Commission’s Seventh Framework 29 Program MeDALL (grant agreement 261357), Foundation Masonic Home for Children in Stockholm, Stockholm County Council, the Swedish Research Council for Health, Working Life and Welfare, and a Swedish Initiative for Research on Microdata in the Social And Medical Science (SIMSAM) framework (grant no. 340-2013-5867).
Author’s contributions
All authors jointly designed the current study. I.K. supervised the data collection. E.D. and I.K. analyzed the data. All authors participated in the interpretation of the findings. E.D. wrote the initial draft. All authors participated in the critical revision of the manuscript, provided important intellectual input, and approved the final version.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Ethics Committee of Karolinska Institutet, Stockholm, Sweden. Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
ESM 1
(TIFF 68 kb)
Rights and permissions
About this article
Cite this article
Dahlén, E., Wettermark, B., Bergström, A. et al. Medicine use and disease control among adolescents with asthma. Eur J Clin Pharmacol 72, 339–347 (2016). https://doi.org/10.1007/s00228-015-1993-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-015-1993-x